Treating Blood Cancers

Daniel Verina, DNP, ACNP-BC, Mount Sinai Medical Center, New York, NY Recorded on October 1, 2021 Advanced practice providers, nurses, and other members of the multidisciplinary healthcare team play an important role in treating and supporting newly diagnosed myeloma patients. In this month’s episode, Daniel Verina, DNP, ACNP-BC, Acute Care Nurse Practitioner, Multiple Myeloma Program, at the Moun...

Joshua Richter, MD, Icahn School of Medicine at Mount Sinai, New York, NY Recorded on September 10, 2021 Treating myeloma patients, especially newly diagnosed, can be very complex. How are treatment decisions determined? Who is eligible to receive a transplant? What is the patient’s role in making treatment decisions? In this month’s episode, Dr. Joshua Richter from the Icahn School of Medicine at...

Lorenzo Falchi, MD and Leah Szumita, MS, RN, CCRN, ACNS-BC Recorded on August 5, 2021 Clinical trials are the foundation of advancing treatment options. Understanding their importance, dispelling myths and fears about enrollment, and acknowledging disparities in access can help providers educate their patients and discuss treatment in a clinical trial as an option at any point in the patient’s can...

David Tate, BSN, RN, PHN, Rio Bravo-Greeley School, Bakersfield, CA Recorded on August 11, 2021 September is Childhood Cancer Awareness Month, a time to recognize the children and families affected by blood cancer. In this month’s special episode, we are joined by David Tate, a registered nurse in the Rio Bravo-Greeley School system in Bakersfield, California to discuss his journey from the father...

Justine M. Kahn, MD, MS, Columbia University Irving Medical Center, New York, NY Recorded on July 13, 2021 Healthcare disparities are a known factor in cancer care. Understanding these disparities can enable healthcare professionals to more effectively communicate with and treat their patients. In this episode, Dr. Justine Kahn, from the Herbert Irving Comprehensive Cancer Center at Columbia Unive...

Steven Horwitz, MD, Memorial Sloan Kettering Cancer Center, New York, NY Recorded on June 18, 2021 Tune in to this very informative and interesting conversation on T-cell lymphoma! Dr. Steven Horwitz, from Memorial Sloan Kettering Cancer Center in New York City, discusses types and diagnostic tests used to identify T-cell lymphoma, goals of treatment, approved and emerging treatment options, inclu...

Jeffrey L. Wolf, MD, University of California San Francisco, San Francisco, CA Recorded on May 27, 2021 In this episode, Dr. Jeffrey Wolf, from the UCSF Helen Diller Family Comprehensive Cancer Center at the University of California San Francisco, explains what measurable residual disease (MRD) is, how providers can explain the role of MRD to patients, including understanding the tests used, how t...

Justin M. Watts, MD, University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL Recorded on May 14, 2021 Terminology, available tests, the impact of epigenetics, and the significance of mutations. Understanding the role of genomics in cancer care can be complex. Tune in as Dr. Justin Watts from the Sylvester Comprehensive Cancer Center in Miami, breaks down cancer genomics, discusses th...

Peter Campbell, PharmD, BCOP, Columbia University Irving Medical Center, New York, NY Recorded on April 23, 2021 The interprofessional oncology team is comprised of many healthcare professionals, each playing an important role in contributing to a patient’s care. Join Dr. Peter Campbell, Clinical Pharmacy Manager from Columbia University Irving Medical Center, as he discusses the vital role of pha...

Edward A. Stadtmauer, MD, The University of Pennsylvania, Philadelphia, PA Recorded on February 23, 2021 In recognition of March being Myeloma Awareness Month, The Leukemia & Lymphoma Society is pleased to share this informative podcast episode on updates and advancements in multiple myeloma. Healthcare professionals are challenged to stay up-to-date on new and emerging treatments options, inc...

Michael Angarone, DO, FIDSA, Feinberg School of Medicine, Chicago, IL Recorded on February 25, 2021 There are so many questions cancer patients and their families have about the COVID-19 vaccine. What are the differences between the vaccines available? How do they work? Who should get vaccinated? Can one resume activities once vaccinated? This important podcast episodes aims to dispel myths surrou...

Sonali M. Smith, MD, FASCO, The University of Chicago, Chicago, IL Recorded on January 25, 2021 How do we start the conversation? How do we discuss patient expectation and the likelihood of relapse? What role does the timing of relapse play? In this episode, Dr. Sonali Smith, the Elwood V. Jensen Professor of Medicine at The University of Chicago, discusses expectations for disease control and for...

Olatoyosi Odenike, MD and Wendy Stock, MD Recorded on January 15, 2021 Join Drs. Wendy Stock and Olatoyosi Odenike from The University of Chicago Medicine, in an important discussion on the progress in the treatment of acute myeloid leukemia, including important updates from the LLS Beat AML Master Trial. Drs. Stock and Odenike talk with Dr. Ken Miller about determining a treatment plan for each p...

Jeff Sharman, MD, Willamette Valley Cancer Institute, Eugene, OR Recorded on December 14, 2020 What is follicular lymphoma and how does it differ from other indolent lymphomas? Can this cancer be cured? Join Dr. Ken Miller as he speaks with Dr. Jeff Sharman, Director of Research at Willamette Valley Cancer Institute and Medical Director of Hematology Research for The US Oncology Network to discuss...

Jennifer Brown, MD, PhD, Dana-Farber Cancer Institute, Boston, MA Recorded on November 19, 2020 Morphology was once the only means of classifying blood cancers especially CLL; flow cytometry, cytogenetics and immunohistochemistry all followed. With a revolution in understanding, there is now a growing list of molecular tests that provide even more precise diagnostic and prognostic tools in diagnos...

Matthew B. Schabath, PhD, Moffitt Cancer Center, Tampa, FL Recorded on November 2, 2020 Individuals in the LGBTQI community face many barriers in accessing healthcare. In this episode, Dr. Matthew Schabath from the Moffitt Cancer Center addresses ways healthcare professionals can be more competent in supporting persons within this community. Dr. Schabath breaks down the terminology and stakeholder...

Gail J. Roboz, MD, Weill Cornell Medical College, New York, NY Recorded on October 2, 2020 Minimal/measurable residual disease (MRD) refers to the small number of cancer cells that remain in the body after treatment. In this episode, Gail Roboz, MD, from Weill Cornell Medical College, provides an overview of MRD, including understanding its definition, explains the role advancements in technology...

Allison J. Applebaum, Ph. D., Memorial Sloan Kettering Cancer Center, New York, NY Recorded on June 26, 2020 Caregivers of patients diagnosed with cancer often don’t allow themselves to connect to the negative emotions that arise. Discussion with Dr. Allison Applebaum focuses on the importance of coaching caregivers to ask for help, problem solve, formulate questions to ask the oncologist, have po...

Carma Bylund, PhD, FACH, and Carla Fisher, PhD Recorded on August 13, 2020 Young adults (YAs) are navigating physical, cognitive, and psychological changes, and transitioning into a more independent time of their life including social life and making more decisions on their own. They often grapple with unique issues when faced with a cancer diagnosis. Carma Bylund, PhD, FACH and Carla Fisher, PhD...

Nicole Gutman, MS, and Mary Kay Irwin, EdD Recorded on May 19, 2020 Children, adolescents, and young adults (AYAs) face unique challenges when returning to school during or after cancer treatment. In this episode, Nicole Gutman, MS, a School Intervention Consultant, and Mary Kay Irwin, EdD, Director of School Health, at Nationwide Children’s Hospital, describe the psychosocial, educational, and co...

James M. Foran, MD, FRCPC, Mayo Clinic Cancer Center, Jacksonville, FL Recorded on May 28, 2020 Listen in as Dr. James Foran from Mayo Clinic defines MDS, discusses the diagnostic workup and factors used to develop a treatment plan, including the importance of the morphology of the bone marrow and the blast count, cytogenetics and next generation sequencing and patient management strategies for lo...

Jennifer Levine, MD, and Maria Luisa Sulis, MD, MS Recorded on June 5, 2020 Since its rise, the conversation surrounding the impact of COVID-19 has been primarily around adults patients. But how does this virus effect pediatric patients, specifically those with a cancer diagnosis? Drs. Jennifer Levine from Weill Cornell Medicine, and Maria Luisa Sulis from Memorial Sloan Kettering Cancer Center, d...

Alison Loren, MD, MSCE, Raymond and Ruth Perelman School of Medicine, Philadelphia, PA Recorded on April 21, 2020 Living with a chronic disease brings with it distinctive and often challenging psychosocial, emotional, and financial challenges. Tune in to this episode as Dr. Alison Loren from The University of Pennsylvania, describes many of the survivorship challenges her patients living with chro...

Raajit K. Rampal, MD, PhD, Memorial Sloan-Kettering Cancer Center, New York, NY Recorded on March 24, 2020 Myeloproliferative neoplasms are an interesting and complex group of blood cancers. Join Dr. Ken Miller as he speaks with Dr. Raajit K. Rampal of Memorial Sloan-Kettering Cancer Center, on how these diseases are categorized and treated. Dr. Rampal shares his insights into disease overlap, dis...

Tobias M. Hohl, MD, PhD, Memorial Sloan-Kettering Cancer Center, New York, NY Recorded on April 15, 2020 As COVID-19 continues to dramatically change the healthcare landscape across the country and the world, what important information do healthcare professionals need to know? In this special episode, Tobias M. Hohl, MD, PhD, Chief, Infectious Diseases Service at Memorial Sloan-Kettering Cancer Ce...